Astellas lines up $5.9B Iveric Bio acquisition

The latest stories trending on MedCity News.

Editor's Pick

Top Story Eying Its Next Blockbuster, Astellas Lines Up $5.9B Iveric Bio Acquisition Astellas Pharma is acquiring Iveric Bio in a deal that brings a vision loss-disorder drug on track for an FDA decision this summer. Iveric's pipeline also includes genetic medicines that fit Astellas's gene therapy strategy. Sponsored Content How Can Healthcare Prevent Data Overload? Presented by Intelligent Medical Objects and MedCity News A new white paper from Intelligent Medical Objects highlights how the aviation, military, law enforcement industries and other sectors confronted data challenges to improve data collection and what the healthcare industry can learn from these examples. Cick here to the download white paper! Check Out the Startups Pitching at INVEST You don't want to miss these innovative startups that will be pitching at INVEST 2023. Be a part of the exciting conversations and networking when you join us in Chicago May 22-24. You still have 5 days left to Save $200. Register Now

Featured News

Is It Possible To Provide Equitable Nutritional Care for Diabetes and Obesity? With obesity, diabetes, and heart disease rapidly growing among communities of color, we need to do everything we can to help people sustain healthy eating habits. It'll take more nuance than a Westernized one-size-fits-all diet. Enrollment in MA Plans With $0 Premiums Is on the Decline, Report Finds In 2023's enrollment period, 84% of eHealth customers chose an MA plan with a $0 monthly premium, versus 87% in 2022, eHealth's annual Medicare Index Report found. This is the first time popularity in $0 premium plans has decreased since eHealth started conducting the report in 2018, when 63% of customers selected a no-premium plan. 60% of Nurses Have Plans to Change Their Job Status in the Coming Year, Study Shows The burnout crisis among nurses has gotten significantly worse since the peak of the pandemic in 2021, according to new research from AMN Healthcare. Only 40% of nurses said that they have no plans to change their work status in the coming year, and only one-third said they have ideal time to spend with their patients — marking a decrease of 10 percentage points from 2021. CVS Health: 60% of Mental Health Physicians See Patients' Conditions Declining New CVS Health data found that while 42% of respondents are concerned about their mental health, only 12% are seeing a mental health professional, such as a psychiatrist, psychologist, psychotherapist or wellbeing therapist. Younger respondents are especially struggling: 60% of those aged 18 to 32 years old are concerned about their mental health. Patient Square Capital Launches Company to Support Medical Device Startups Healthcare investment firm Patient Square Capital launched a new portfolio company: Elevage Medical Technologies. The company will support growth-stage medical device companies by providing capital, as well as operational and clinical expertise — it received an initial investment of $300 million from Patient Square.

Resources

Season 2 of MedCity Pivot Podcast Launches with Conversation of Zephyr AI CTO This season, we will be focusing on artificial intelligence in healthcare. Our very first interview is with Jeff Sherman, chief technology officer of Zephyr AI, a company that aims to transform precision medicine from diagnostics to treatment. How exactly does it plan to do that? Listen to find out.  Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe